Indogulf Cropsciences（IGCL）株式概要インドガルフ・クロップサイエンシズ社は、作物保護製品、植物栄養剤、生物学的製品を製造し、インド国内および海外の小売業者や機関投資家向けに販売している。 詳細IGCL ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績5/6財務の健全性4/6配当金0/6報酬株価収益率（ 9.8 x） Indian市場（ 23.1 x）を下回っています。過去1年間で収益は27.2%増加しました リスク分析意味のある時価総額がありません ( ₹4B )すべてのリスクチェックを見るIGCL Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹62.19137.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture07b2016201920222025202620282031Revenue ₹7.1bEarnings ₹400.3mAdvancedSet Fair ValueView all narrativesIndogulf Cropsciences Limited 競合他社Shivalik RasayanSymbol: BSE:539148Market cap: ₹3.5bRama PhosphatesSymbol: BSE:524037Market cap: ₹4.3bAries AgroSymbol: BSE:532935Market cap: ₹4.4bNova AgritechSymbol: NSEI:NOVAAGRIMarket cap: ₹2.5b価格と性能株価の高値、安値、推移の概要Indogulf Cropsciences過去の株価現在の株価₹62.1952週高値₹122.0052週安値₹49.46ベータ01ヶ月の変化1.04%3ヶ月変化7.52%1年変化n/a3年間の変化n/a5年間の変化n/aIPOからの変化-43.64%最新ニュースReported Earnings • May 30Full year 2026 earnings released: EPS: ₹6.72 (vs ₹6.45 in FY 2025)Full year 2026 results: EPS: ₹6.72 (up from ₹6.45 in FY 2025). Revenue: ₹7.12b (up 20% from FY 2025). Net income: ₹400.3m (up 27% from FY 2025). Profit margin: 5.6% (up from 5.3% in FY 2025). The increase in margin was driven by higher revenue.お知らせ • May 22Indogulf Cropsciences Limited to Report Q4, 2026 Results on May 28, 2026Indogulf Cropsciences Limited announced that they will report Q4, 2026 results on May 28, 2026Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹62.41, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India.New Risk • Feb 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Market cap is less than US$100m (₹4.47b market cap, or US$49.3m).Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.77 (vs ₹0.86 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.77. Revenue: ₹1.19b (up 19% from 3Q 2025). Net income: ₹38.6m (up 5.6% from 3Q 2025). Profit margin: 3.3% (down from 3.7% in 3Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Feb 06Indogulf Cropsciences Limited to Report Q3, 2026 Results on Feb 11, 2026Indogulf Cropsciences Limited announced that they will report Q3, 2026 results on Feb 11, 2026最新情報をもっと見るRecent updatesReported Earnings • May 30Full year 2026 earnings released: EPS: ₹6.72 (vs ₹6.45 in FY 2025)Full year 2026 results: EPS: ₹6.72 (up from ₹6.45 in FY 2025). Revenue: ₹7.12b (up 20% from FY 2025). Net income: ₹400.3m (up 27% from FY 2025). Profit margin: 5.6% (up from 5.3% in FY 2025). The increase in margin was driven by higher revenue.お知らせ • May 22Indogulf Cropsciences Limited to Report Q4, 2026 Results on May 28, 2026Indogulf Cropsciences Limited announced that they will report Q4, 2026 results on May 28, 2026Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹62.41, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India.New Risk • Feb 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Market cap is less than US$100m (₹4.47b market cap, or US$49.3m).Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.77 (vs ₹0.86 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.77. Revenue: ₹1.19b (up 19% from 3Q 2025). Net income: ₹38.6m (up 5.6% from 3Q 2025). Profit margin: 3.3% (down from 3.7% in 3Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Feb 06Indogulf Cropsciences Limited to Report Q3, 2026 Results on Feb 11, 2026Indogulf Cropsciences Limited announced that they will report Q3, 2026 results on Feb 11, 2026お知らせ • Nov 08Indogulf Cropsciences Limited to Report Q2, 2026 Results on Nov 12, 2025Indogulf Cropsciences Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Sep 30Indogulf Cropsciences Limited Appoints Snehal Kashyap as an Independent, Professional and Non- Executive DirectorIndogulf Cropsciences Limited announced the appointment of Mrs. Snehal Kashyap as an independent, professional and Non- executive Director.お知らせ • Sep 03Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025, at 13:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹115, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 27x in the Chemicals industry in India.お知らせ • Aug 09Indogulf Cropsciences Limited to Report Q1, 2026 Results on Aug 13, 2025Indogulf Cropsciences Limited announced that they will report Q1, 2026 results on Aug 13, 2025お知らせ • Jul 21Indogulf Cropsciences Limited to Report Fiscal Year 2025 Results on Jul 24, 2025Indogulf Cropsciences Limited announced that they will report fiscal year 2025 results on Jul 24, 2025New Risk • Jul 09New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (₹6.51b market cap, or US$75.8m).お知らせ • Jul 02Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion.Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 6,235,900 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 5,243,242 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 3,665,183 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 2,672,529 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 223,290 Price\Range: INR 100 Discount Per Security: INR 4.72 Transaction Features: Regulation S; Reserved Share Offering株主還元IGCLIN ChemicalsIN 市場7D13.0%0.8%0.05%1Yn/a-3.9%-2.0%株主還元を見る業界別リターン: IGCLがIndian Chemicals業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: IGCL Indian市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is IGCL's price volatile compared to industry and market?IGCL volatilityIGCL Average Weekly Movement7.4%Chemicals Industry Average Movement7.3%Market Average Movement7.1%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%安定した株価: IGCL 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: IGCLの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1993700Sanjay Aggarwalwww.groupindogulf.comインドガルフ・クロップサイエンシズ社は、作物保護製品、植物栄養剤、生物学的製剤を製造し、インド国内および海外の小売業者や機関投資家向けに販売している。殺虫剤、殺菌剤、除草剤、植物成長調整剤、微量肥料、抗生物質などの農薬製剤、生物活性剤、水分散性顆粒剤、濃縮懸濁剤、カプセル懸濁剤、超低容量剤、水中乳濁剤、可溶性顆粒剤、流動性懸濁剤などのその他の製剤を提供している。製品の輸出も行っている。Indogulf Cropsciences Limitedの前身はJai Shree Rasayan Udyog Limitedで、2015年4月にIndogulf Cropsciences Limitedに社名変更した。Indogulf Cropsciences Limitedは1993年に設立され、インドのニューデリーに拠点を置く。もっと見るIndogulf Cropsciences Limited 基礎のまとめIndogulf Cropsciences の収益と売上を時価総額と比較するとどうか。IGCL 基礎統計学時価総額₹3.93b収益（TTM）₹400.27m売上高(TTM)₹7.12b9.8xPER（株価収益率0.6xP/SレシオIGCL は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計IGCL 損益計算書（TTM）収益₹7.12b売上原価₹4.86b売上総利益₹2.26bその他の費用₹1.86b収益₹400.27m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）6.33グロス・マージン31.68%純利益率5.62%有利子負債／自己資本比率38.5%IGCL の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/15 17:18終値2026/06/15 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Indogulf Cropsciences Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 30Full year 2026 earnings released: EPS: ₹6.72 (vs ₹6.45 in FY 2025)Full year 2026 results: EPS: ₹6.72 (up from ₹6.45 in FY 2025). Revenue: ₹7.12b (up 20% from FY 2025). Net income: ₹400.3m (up 27% from FY 2025). Profit margin: 5.6% (up from 5.3% in FY 2025). The increase in margin was driven by higher revenue.
お知らせ • May 22Indogulf Cropsciences Limited to Report Q4, 2026 Results on May 28, 2026Indogulf Cropsciences Limited announced that they will report Q4, 2026 results on May 28, 2026
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹62.41, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India.
New Risk • Feb 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Market cap is less than US$100m (₹4.47b market cap, or US$49.3m).
Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.77 (vs ₹0.86 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.77. Revenue: ₹1.19b (up 19% from 3Q 2025). Net income: ₹38.6m (up 5.6% from 3Q 2025). Profit margin: 3.3% (down from 3.7% in 3Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Feb 06Indogulf Cropsciences Limited to Report Q3, 2026 Results on Feb 11, 2026Indogulf Cropsciences Limited announced that they will report Q3, 2026 results on Feb 11, 2026
Reported Earnings • May 30Full year 2026 earnings released: EPS: ₹6.72 (vs ₹6.45 in FY 2025)Full year 2026 results: EPS: ₹6.72 (up from ₹6.45 in FY 2025). Revenue: ₹7.12b (up 20% from FY 2025). Net income: ₹400.3m (up 27% from FY 2025). Profit margin: 5.6% (up from 5.3% in FY 2025). The increase in margin was driven by higher revenue.
お知らせ • May 22Indogulf Cropsciences Limited to Report Q4, 2026 Results on May 28, 2026Indogulf Cropsciences Limited announced that they will report Q4, 2026 results on May 28, 2026
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹62.41, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India.
New Risk • Feb 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Market cap is less than US$100m (₹4.47b market cap, or US$49.3m).
Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.77 (vs ₹0.86 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.77. Revenue: ₹1.19b (up 19% from 3Q 2025). Net income: ₹38.6m (up 5.6% from 3Q 2025). Profit margin: 3.3% (down from 3.7% in 3Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Feb 06Indogulf Cropsciences Limited to Report Q3, 2026 Results on Feb 11, 2026Indogulf Cropsciences Limited announced that they will report Q3, 2026 results on Feb 11, 2026
お知らせ • Nov 08Indogulf Cropsciences Limited to Report Q2, 2026 Results on Nov 12, 2025Indogulf Cropsciences Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Sep 30Indogulf Cropsciences Limited Appoints Snehal Kashyap as an Independent, Professional and Non- Executive DirectorIndogulf Cropsciences Limited announced the appointment of Mrs. Snehal Kashyap as an independent, professional and Non- executive Director.
お知らせ • Sep 03Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025, at 13:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹115, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 27x in the Chemicals industry in India.
お知らせ • Aug 09Indogulf Cropsciences Limited to Report Q1, 2026 Results on Aug 13, 2025Indogulf Cropsciences Limited announced that they will report Q1, 2026 results on Aug 13, 2025
お知らせ • Jul 21Indogulf Cropsciences Limited to Report Fiscal Year 2025 Results on Jul 24, 2025Indogulf Cropsciences Limited announced that they will report fiscal year 2025 results on Jul 24, 2025
New Risk • Jul 09New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (₹6.51b market cap, or US$75.8m).
お知らせ • Jul 02Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion.Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 6,235,900 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 5,243,242 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 3,665,183 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 2,672,529 Price\Range: INR 111 Discount Per Security: INR 5.2392 Security Name: Equity Shares Security Type: Common Stock Securities Offered: 223,290 Price\Range: INR 100 Discount Per Security: INR 4.72 Transaction Features: Regulation S; Reserved Share Offering
